Organ-on-a-Chip Models for Pancreatic Cancer Research

Tianxiu Lin

International Journal of Sciences, 2020, vol. 9, issue 02, 49-56

Abstract: Pancreatic cancer is the one of lowest survival rate cancer among all kinds of cancer. This is because its early syndromes are very different from other fatal diseases. Although with the development of the detection and management, more than 96% of the patients cannot live more than 5 years after diagnosis. Survival rate is low for those with malignant disease in the pancreas, because surgical resection at present may cut off the only chance of the cure. Unfortunately, 80–85% of patients are present with advanced unresectable pathology. Furthermore, pancreatic cancer responds poorly to most chemotherapeutic agents. Therefore, many scientists have devoted tons of efforts into the field of pancreatic cancer. With the development of biotechnology and medicine, a rising tech named Organ-on-a-chip shows astonishing capability of monitoring and modeling cancer. In the following passage, it provides an overview of the advanced technology in research on pancreatic cancer.

Keywords: Pancreatic Cancer; Chemotherapeutic Agents; Organ-On-A-Chip (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.ijsciences.com/pub/article/2253 (text/html)
https://www.ijsciences.com/pub/pdf/V92020022253.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adm:journl:v:9:y:2020:i:2:p:49-56

Ordering information: This journal article can be ordered from
https://www.ijsciences.com/payment_guide.php

DOI: 10.18483/ijSci.2253

Access Statistics for this article

More articles in International Journal of Sciences from Office ijSciences Alkhaer Publications Manchester M8 8XG England.
Bibliographic data for series maintained by Staff ijSciences ().